Literature DB >> 32885614

Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups.

Alyssa M Civantos1, Ivy W Maina1, Monique Arnold1, Cailu Lin2, Elizabeth M Stevens1, Li Hui Tan3, Patrick K Gleeson1, Lauren R Colquitt2, Beverly J Cowart2, John V Bosso1, James N Palmer1, Nithin D Adappa1, Michael A Kohanski1, Danielle R Reed2, Noam A Cohen1,2,3.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP), and aspirin-exacerbated respiratory disease (AERD) have varying levels of inflammation and disease severity. Solitary chemosensory cells (SCCs) are enriched in nasal polyps, are the primary source of interleukin 25 (IL-25) in upper airways, leading to type 2 inflammation, and are activated by bitter-tasting denatonium benzoate (DB). Thus, we sought to evaluate DB taste perception at a range of concentrations in order to identify 1 that most differentiates CRS subgroups from controls.
METHODS: CRSsNP (n = 25), CRSwNP (n = 26), and AERD (n = 27) patients as well as controls (n = 25) tasted 6 DB concentrations in a fixed, random order, rating on a category scale of 0 (no intensity) to 12 (extremely intense). Sinonasal epithelial cultures were treated with and without denatonium and analyzed for IL-25 via flow cytometry.
RESULTS: CRSsNP patients rated DB as significantly less intense than did controls at all concentrations: 5.62 × 10-9 M, 1.00 × 10-8 M, 1.78 × 10-8 M, 3.16 × 10-8 M, 5.62 × 10-8 M, and 1.00 × 10-7 M (all p < 0.0083). CRSwNP patients did not show significant differences from controls. AERD patients rated DB as significantly more intense than did controls at concentrations of 1.00 × 10-8 M and 3.16 × 10-8 M (p < 0.0083). In vitro data demonstrated significant increase in IL-25-positive cells after denatonium stimulation (n = 5), compared to control (n = 5) (p = 0.012).
CONCLUSION: Our findings link in vitro DB stimulation of sinonasal tissue with increased IL-25 and show differential DB taste perception in CRS subgroups relative to the control group, with CRSsNP being hyposensitive and AERD being hypersensitive. We propose a concentration of 3.16 × 10-8 M for future study of clinical utility.
© 2020 ARS-AAOA, LLC.

Entities:  

Keywords:  AERD; bitter taste receptors; bitterness; mucosal immunity; sensory perception; solitary chemosensory cells; type 2 inflammation

Year:  2020        PMID: 32885614     DOI: 10.1002/alr.22687

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  3 in total

1.  Taste receptors in chronic rhinosinusitus, what is the evidence? A systematic review.

Authors:  Jonathan H Chen; Christopher I Song; Nanki Hura; Anirudh Saraswathula; Stella M Seal; Andrew P Lane; Nicholas R Rowan
Journal:  Int Forum Allergy Rhinol       Date:  2022-01-05       Impact factor: 5.426

Review 2.  Taste Receptors: The Gatekeepers of the Airway Epithelium.

Authors:  Katleen Martens; Brecht Steelant; Dominique M A Bullens
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 3.  Tuft cells in the pathogenesis of chronic rhinosinusitis with nasal polyps and asthma.

Authors:  Elizabeth A Sell; Jorge F Ortiz-Carpena; De'Broski R Herbert; Noam A Cohen
Journal:  Ann Allergy Asthma Immunol       Date:  2020-10-26       Impact factor: 6.347

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.